Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.
Start 7-day free trial → Log in

Telithromycin · Ketek, HMR-3647

Small molecule · developed by Sanofi Aventis Us

Approved FDA, Apr 2004
1 Registered trials

What is Telithromycin?

Telithromycin is a ketolide antibacterial drug.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Ketek, HMR-3647, NSC-758940
Drug type
Small molecule
Therapy area
Infectious disease, Respiratory
Developer
Sanofi Aventis Us
In trials of
ENTA
FDA status
Approved as Ketek (April 1, 2004), NDA021144 · FDA label
UNII
KI8H7H19WL

✅ FDA-approved uses

From the indications section of the FDA label (version of Apr 20, 2017). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT00270517 Phase 2 Community Acquired Pneumonia Unknown ENTA

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Community Acquired Pneumonia

Sources

Updated Oct 11, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.